These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6274091)

  • 41. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 42. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
    Lin JC; Smith MC
    Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus.
    Saemundsen AK; Kallin B; Klein G
    Virology; 1980 Dec; 107(2):557-61. PubMed ID: 6256952
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 45. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Hammerschmidt W; Sugden B
    Cell; 1988 Nov; 55(3):427-33. PubMed ID: 2846181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir.
    Colby BM; Shaw JE; Datta AK; Pagano JS
    Am J Med; 1982 Jul; 73(1A):77-81. PubMed ID: 6285738
    [No Abstract]   [Full Text] [Related]  

  • 48. Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji.
    Polack A; Delius H; Zimber U; Bornkamm GW
    Virology; 1984 Feb; 133(1):146-57. PubMed ID: 6322426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus-associated thymidine kinase.
    Chen ST; Estes JE; Huang ES; Pagano JS
    J Virol; 1978 Apr; 26(1):203-8. PubMed ID: 206728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus DNA replication.
    Frey A; Chittenden T; Levine AJ
    Curr Top Microbiol Immunol; 1989; 144():227-32. PubMed ID: 2551584
    [No Abstract]   [Full Text] [Related]  

  • 51. Repression of the viral latent promoter BC-R2 in Epstein-Barr virus negative cell lines.
    Klonjkowski B; Walls D; Gilardi-Hebenstreit P; Perricaudet M
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1695-700. PubMed ID: 1336378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus silver anniversary.
    Lancet; 1989 May; 1(8648):1171-3. PubMed ID: 2566738
    [No Abstract]   [Full Text] [Related]  

  • 53. [Inhibition and reversion of Epstein-Barr virus DNA replication in the H18 cell line].
    Zhao DB
    Shi Yan Sheng Wu Xue Bao; 1987 Mar; 20(1):53-60. PubMed ID: 2820170
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus.
    Feighny RJ; Henry BE; Datta AK; Pagano JS
    Virology; 1980 Dec; 107(2):415-23. PubMed ID: 6256941
    [No Abstract]   [Full Text] [Related]  

  • 55. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
    Srinivas SK; Sample JT; Sixbey JW
    J Infect Dis; 1998 Jun; 177(6):1705-9. PubMed ID: 9607853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of arabinofuranosylthymine on Epstein-Barr virus replication.
    Ooka T; Calender A
    Virology; 1980 Jul; 104(1):219-23. PubMed ID: 6249024
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 58. [Epstein-Barr virus; gene expression and replication].
    Shimizu N; Takada K
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2532-41. PubMed ID: 1332122
    [No Abstract]   [Full Text] [Related]  

  • 59. A cosmid system for the analysis of lytic replication of Epstein-Barr virus.
    Hung CH; Kwang MJ; Liu ST
    Anal Biochem; 1999 Sep; 273(2):315-8. PubMed ID: 10469506
    [No Abstract]   [Full Text] [Related]  

  • 60. The ecology and pathology of Epstein-Barr virus.
    Schmidt CW; Misko IS
    Immunol Cell Biol; 1995 Dec; 73(6):489-504. PubMed ID: 8713470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.